Coordinating Care After Cancer

For cancer survivors, health care is anything but routine.

Talk about this article with other patients, caregivers, and advocates in the General Discussions CURE discussion group.
Peter Noble is eager to close the book on cancer, or at least get it down to a novella, and move on. Noble, 57, learned in November 2009 that he had cancer of the tonsils that was staged between 2 and 3. Thirty-five radiation treatments and three rounds of chemotherapy meant he had to use a stomach tube for six months.

Noble's treatment ended in March 2010, and for a year he saw his internist, his head and neck surgeon, his medical oncologist and his radiation oncologist every three months. Each of them had a slightly different approach to Noble’s follow-up care. In May 2011, he stopped seeing his radiation oncologist. 

“They were duplicating follow-up, and he seemed the best one to drop,” Noble says. 

When he asked his head and neck surgeon about seeing only one specialist, the doctor offered to send a letter to the medical and radiation oncologists and work it out. His last visit was spent between the two offices trying to determine which scan was needed. Then, when he decided to stop seeing one oncologist and be followed by the head and neck surgeon, he received a registered letter from the oncologist asking him to come in.

“It’s confusing, costly and possibly unnecessary,” he says. “I’m grateful for this team; they saved my life. But I’m looking forward to the day, which my doctors say may be in four or five years, when I can transfer all my care to my internist.”

The concept of long-term cancer survival is relatively new, and even professionals concede there is no consensus on what care should look like or who should provide it. In 2005, the Institute of Medicine issued From Cancer Patient to Cancer Survivor: Lost in Transition, a comprehensive look at the needs of survivors, which listed four components of quality cancer survivorship care: 

> Prevention of recurrent and new cancers, and of other late effects;

> Surveillance for cancer spread, recurrence or second cancers; assessment of medical and psychosocial late effects;

> Intervention to help with effects of cancer and its treatment; and

> Coordination between specialists and primary care providers to ensure that all of the survivor’s health needs are met.

As most healthcare professionals know, these are ambitious goals, and a nationwide survey of medical oncologists and PCPs concerning cancer survivorship care released at the American Society of Clinical Oncology’s annual meeting in Chicago has shed some light on a few of the challenges to achieving them. 

Sponsored by the National Cancer Institute and the American Cancer Society, the survey found that those PCPs who were following breast and colon cancer survivors for five or more years after their initial cancer treatment were more likely than oncologists to order tests or treatments as malpractice protection. The PCPs also reported being concerned about their lack of training to manage patient problems. 

“Primary care physicians expressed a lack of training in essential content areas pertaining to survivorship care,” says Katherine S. Virgo, PhD, managing director of health services research for the American Cancer Society and lead author of the study. “Continuing education plus the provision of a treatment summary and survivorship care plan are needed to reduce barriers on the part of the primary care physician.”

Until there is a clear path for patients, Lost in Transition says the starting point and essential ingredient in follow-up care is a comprehensive care summary and survivorship care plan. 

Ideally, a patient’s oncologist or nurse would, at the end of treatment, create a document that carefully explains therapy, follow-up care and what to expect in the future. 

But heavy patient loads and lack of insurance reimbursement for time spent on creating care plans are persistent problems.

“So many newly diagnosed people are coming through the front door to be treated,” says Richard Boyajian, RN, NP, clinical director of the Lance Armstrong Foundation Adult Survivorship Program at the Dana-Farber Cancer Institute in Boston. “There aren’t enough oncologists as it is. Asking an overwhelmed provider to take the time to create a care plan for each patient finishing treatment is fantasyland.”

Boyajian advises a more succinct approach. “When your treatment is complete, be proactive to get as much information as you can,” he says, suggesting you ask your provider some basic questions: What is my cancer type, stage and other critical characteristics? What was I treated with? Does this treatment put me at any risk? What follow-up do I need?

Survivors need to educate themselves, advocate for themselves, keep current on findings about late effects and update their treatment summary and care plan annually. Many times, they need to educate the PCP provider as well.

Talk about this article with other patients, caregivers, and advocates in the General Discussions CURE discussion group.
Cure Connections
Related Articles
Pairing Radiation Oncology and Palliative Care Leads to Better Outcomes
A novel service model allowed for shorter durations of treatment with radiation, fewer unfinished treatments with radiation, shorter hospital stays and increased use of palliative care.
Buying Hope: Life After a Fertility-Threatening Diagnosis
It’s all about having a plan. Plans give hope. Plans inspire.
A View From a Young Lung Cancer Survivor: Genomic Testing Provides Hope
To gain a patient’s perspective on the Genomics of Young Lung Cancer Study and the importance of genomic testing, we spoke with Corey Wood, a 23-year-old trial participant and lung cancer survivor.
Chemo Brain: A Breast Cancer Survivor's Commentary
Two-time cancer survivor struggles living with chemo brain.
Varubi Represents 'Another Tool in the Toolbox' for CINV
The approval of Varubi was based on data from several phase 3 trials of the agent in more than 2,500 patients receiving various emetogenic chemotherapy agents.
Related Videos
Sharon L. Bober on Sexual Health Changes in Relation to Treatment
Sharon L. Bober, director, Sexual Health Program, Dana-Farber Cancer Institute, discusses changes in sexual health as they relate to different treatments for cancer.
Ginny Finn on the Importance of Addressing Breast Cancer Survivorship Issues
Finn says it’s important for advocacy organizations to attend and socialize at these conferences to explore possible collaborations.
Gwendolyn P. Quinn on the Need to Educate Health Care Providers on Reproductive Health
Gwendolyn P. Quinn, member, Moffitt Cancer Center, comments on the need to educate all health care providers — especially those caring for patients with cancer — on sexual and reproductive health.
Gwendolyn P. Quinn on Infertility Among Survivors of Adolescent and Young Adult Cancers
Gwendolyn P. Quinn, member, Moffitt Cancer Center, discusses causes and effects of infertility among survivors of adolescent and young adults cancers.
Hope Rugo on Managing Sexual Dysfunction From Ovarian Suppression
Hope S. Rugo discusses managing sexual dysfunction from ovarian suppression treatment for breast cancer.